Get started
Author

Sean S. S. Hwang

Observed names: Hwang, Sean Soon Sung, Sean Soon Sung Hwang
Institution: CHA University
ORCID: 0000-0002-1922-7964
Observed ORCID: 0000-0002-1922-7964
OpenAlex ID: A5028169215
Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury
2018 · Min-Jae Jo, Hemant Kumar, et al. · Frontiers in Pharmacology · 26
PDF
The Korean Version of the Oxford Cognitive Screen (K-OCS) Normative Study
2024 · Eunyoung Cho, Sungwon Choi, et al. · Annals of Rehabilitation Medicine · 4
PDF
Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2025 · Jong Moon Kim, Seyoung Shin, et al. · Stem Cell Research & Therapy · 2
Corrigendum: Oral Administration of α-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury
2018 · Min-Jae Jo, Hemant Kumar, et al. · Frontiers in Pharmacology · 2
PDF
Additional file 4 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 11 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 6 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 5 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 12 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 3 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 10 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 7 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 8 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 1 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 9 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Additional file 2 of Safety and efficacy of allogeneic umbilical cord blood cells and erythropoietin combination therapy in patients with subacute stroke
2026 · Kim, Jong Moon, Shin, Seyoung, et al. · Figshare
Works count: 17
Citation count: 34
H-index: 2
I10-index: 1
Year
Topic
Type